Inhibitor Therapeutics (INTI) Return on Capital Employed [ROCE] (2014 - 2026)
Inhibitor Therapeutics' Return on Capital Employed [ROCE] was -391.75% in Q2 2026, down 301.56 percentage points from -90.19% a year earlier and down 174.91 percentage points from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Inhibitor Therapeutics came in at -102.70%, down 47.39 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for three consecutive years, though with a five-year change of +1068.02 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -55.31% in FY2024 (-20.56 pp), -34.76% in FY2023 (-22.43 pp) and -12.32% in FY2022.
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q1 2020.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 11 straight quarters, with an average year-over-year change of -90.67 percentage points over the last eight quarters.
- Across the past five years, year-over-year drop in Return on Capital Employed [ROCE] ran from 24.65 percentage points in Q3 2024 to 301.56 percentage points in Q2 2026.
- Per Business Quant data, INTI's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -216.84% (Q1 2026), -166.59% (Q4 2025) and -104.71% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | -391.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -391.75% |
| Mar 31, 2026 | -216.84% |
| Dec 31, 2025 | -166.59% |
| Sep 30, 2025 | -104.71% |
| Jun 30, 2025 | -90.19% |
| Mar 31, 2025 | -71.07% |
| Dec 31, 2024 | -68.19% |
| Sep 30, 2024 | -50.92% |
| Jun 30, 2024 | -45.55% |
| Mar 31, 2024 | -43.21% |
| Dec 31, 2023 | -39.53% |
| Sep 30, 2023 | -26.27% |
| Jun 30, 2023 | -17.85% |
| Mar 31, 2023 | -10.54% |
| Dec 31, 2022 | -12.32% |
| Mar 31, 2020 | -773.53% |
| Dec 31, 2019 | -361.18% |
| Sep 30, 2019 | -237.41% |
| Jun 30, 2019 | -283.44% |
| Mar 31, 2019 | -455.47% |
API Access
Inhibitor Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();